Induction of the Abscopal Effect with Immunotherapy and Palliative Radiation in Metastatic Head and Neck Squamous Cell Carcinoma: A Case Report and Review of the Literature

This publication has 15 references indexed in Scilit:

• Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide
  Clinical and Translational Radiation Oncology, 2018
• Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review
  Medical Oncology, 2018
• Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
  New England Journal of Medicine, 2016
• Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
  The Lancet Oncology, 2016
• Systematic review of case reports on the abscopal effect
  Current Problems in Cancer, 2016
• Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
  Journal of Clinical Investigation, 2014
• Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
  New England Journal of Medicine, 2012
• Systemic effects of local radiotherapy
  The Lancet Oncology, 2009
• Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
  New England Journal of Medicine, 2008
• The ‘QUAD SHOT’—a phase II study of palliative radiotherapy for incurable head and neck cancer
  Radiotherapy and Oncology, 2005